Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

DEK reported for 3 months of 2025 by RAS

4/30/25 DVEC

Kamaz in Q1 increased truck output by 2.5%

4/30/25 KMAZ

Fix Price reported for 3 months of 2025 by IFRS

4/30/25 FIXP

Fix Price's LFL traffic in Q1 continued to decline

4/30/25 FIXP

Demand for Delimobil in Q1 decreased by 13%c

4/30/25 DELI

O'Key's Q1 revenue grew by 2.6%

4/30/25 OKEY

Board of Directors of Acron recommended that dividends be paid for 2024

4/30/25 AKRN

Board of Directors of Acron recommended that dividends be paid for 2024

4/30/25 AKRN

UTair Aviation reported for 3 months of 2025 by RAS

4/30/25 UTAR

KuibyshevAzot reported for 3 months of 2025 by RAS

4/30/25 KAZT